Perspectify News
4 hours ago
Fresh medicine news from the world
Provided by AGP
AGP Picks
View all
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
3 hours ago
Medical camp conducted for sanitation workers
Press releases
Publish your press release
3 hours ago
Blossom Ridge Medical Inc. and Bloom Value Team Up for CMS ACCESS Model Participation
EIN Presswire
Blossom Ridge Medical Inc. and Bloom Value collaborate to advance value-based care through participation in CMS ACCESS Model.
4 hours ago
Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
GlobeNewswire, Inc.
New company (“NewCo”) co-founded by Nxera with a syndicate of leading healthcare and life sciences-focused investment firms.
10 hours ago
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire, Inc.
NEW YORK, May 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that...
17 hours ago
Cybersecurity Top Reason The FDA Rejects Medical Device Submissions, Says Blue Goat Cyber's Christian Espinosa
EIN Presswire
FDA premarket rejections have surged since the February 2026 cybersecurity guidance.
May. 9, 2026
Top API Manufacturer Expands Innovation and Global Supply Capabilities in Pharmaceutical Development
EIN Presswire
TAIZHOU, ZHEJIANG, CHINA, May 9, 2026 /EINPresswire.com/ -- Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing...
May. 6, 2026
Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response
GlobeNewswire, Inc.
PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics...
Video Stories
Discover Affinity Group Publishing
Sign up for:
Today in Medicine
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
